免疫微环境和免疫疗法用于胆瘤
1Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Frontiers in oncology
|July 10, 2024
概括
冠状瘤免疫疗法对这种罕见的骨癌显示出有前途. 研究瘤的研究.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 冠状瘤是一种罕见的,生长缓慢的恶性瘤,通常会侵入周围的骨和组织.
- 完整的手术切除是具有挑战性的,并且瘤对传统疗法具有抗性,需要新的治疗策略.
- 免疫疗法已经成为各种癌症的有希望的治疗方法,为诸如冠状瘤等难治的瘤提供了新的希望.
研究的目的:
- 审查有关瘤免疫微环境的当前研究.
- 分析免疫疗法研究和冠状动脉瘤临床试验的状态.
- 为了确定科研边界和限制在chordoma免疫疗法.
主要方法:
- 关于chordoma的免疫微环境研究的文献综述.
- 分析免疫细胞透,瘤特异性抗原表达和瘤中的免疫检查点表达.
- 审查正在进行的和已完成的临床试验为chordoma免疫疗法.
主要成果:
- 研究揭示了对chordoma的免疫微环境的见解,重点关注免疫细胞透和抗原/检查点表达.
- 目前正在研究几种免疫疗法治疗心脏瘤的方法,其中一些方法显示了令人鼓舞的初步结果.
- 现有的临床试验数据为了解瘤免疫疗法的潜力和挑战提供了基础.
结论:
- 了解免疫微环境对于开发有效的冠状腺瘤免疫疗法至关重要.
- 目前正在进行的免疫疗法研究和临床试验为心脏瘤患者提供了潜在的新治疗途径.
- 需要进一步的研究来克服局限性并优化心脏瘤的免疫治疗策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509


